Multimodal Imaging of 2-Cycle PRRT with (177)Lu-DOTA-JR11 and (177)Lu-DOTATOC in an Orthotopic Neuroendocrine Xenograft Tumor Mouse Model

Peptide receptor radionuclide therapy (PRRT) using radiolabeled somatostatin receptor (SSTR) analogs is a common approach in advanced neuroendocrine neoplasms. Recently, SSTR antagonists have shown promising results for imaging and therapy due to a higher number of binding sites than in commonly use...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Nucl Med
Asıl Yazarlar: Albrecht, Jakob, Exner, Samantha, Grötzinger, Carsten, Prasad, Sonal, Konietschke, Frank, Beindorff, Nicola, Kühl, Anja A., Prasad, Vikas, Brenner, Winfried, Koziolek, Eva J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Society of Nuclear Medicine 2021
Konular:
Theranostics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8049340/
https://ncbi.nlm.nih.gov/pubmed/32859703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.120.250274
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller